Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$0.7 - $0.98 $700 - $980
-1,001 Reduced 88.82%
126 $0
Q3 2023

Nov 09, 2023

SELL
$0.58 - $1.41 $878 - $2,136
-1,515 Reduced 57.34%
1,127 $0
Q2 2023

Aug 09, 2023

BUY
$0.56 - $1.2 $1,389 - $2,977
2,481 Added 1540.99%
2,642 $2,000
Q1 2023

May 12, 2023

SELL
$0.59 - $0.86 $1,931 - $2,814
-3,273 Reduced 95.31%
161 $0
Q4 2022

Feb 09, 2023

SELL
$0.61 - $8.13 $16,599 - $221,233
-27,212 Reduced 88.79%
3,434 $2,000
Q3 2022

Nov 09, 2022

BUY
$0.73 - $8.65 $6,135 - $72,703
8,405 Added 37.79%
30,646 $25,000
Q2 2022

Aug 11, 2022

SELL
$0.75 - $1.33 $15,716 - $27,870
-20,955 Reduced 48.51%
22,241 $17,000
Q1 2022

May 12, 2022

BUY
$1.09 - $1.83 $21,944 - $36,843
20,133 Added 87.3%
43,196 $56,000
Q4 2021

Feb 11, 2022

BUY
$1.63 - $2.83 $37,592 - $65,268
23,063 New
23,063 $38,000
Q2 2021

Aug 10, 2021

SELL
$3.3 - $5.02 $267 - $406
-81 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$4.29 - $9.94 $347 - $805
81 New
81 $0

Others Institutions Holding EVGN

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $103M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.